Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

Abstract Background Microtubule-associated protein Tau (MAPT) overexpression has been linked to poor prognosis and decreased response to taxane-based therapies in several cancer types, but its relevance in prostate cancer is unknown. Methods In this study, MAPT expression was analyzed by immunohisto...

Full description

Bibliographic Details
Main Authors: Cornelia Schroeder, Jan Grell, Claudia Hube-Magg, Martina Kluth, Dagmar Lang, Ronald Simon, Doris Höflmayer, Sarah Minner, Eike Burandt, Till S. Clauditz, Franziska Büscheck, Frank Jacobsen, Hartwig Huland, Markus Graefen, Thorsten Schlomm, Guido Sauter, Stefan Steurer
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Cancer
Subjects:
MAPT
Tau
ERG
PTEN
Deletion
Prostate cancer
Online Access:http://link.springer.com/article/10.1186/s12885-019-5390-1

Internet

http://link.springer.com/article/10.1186/s12885-019-5390-1

Similar Items